• A Drug to Remember

  • 2021/07/10
  • 再生時間: 27 分
  • ポッドキャスト

  • サマリー

  • Listen to hosts Samantha Spiers and Wildcard Cameron discuss the FDA's approval of Aduhelm, a new drug developed to treat those with Alzheimer's disease. Discussion includes what is this drug, why is its approval controversial, and why did the FDA go ahead and approve it.

        

    Post production by Scott Stronach.   


    Check out other Sample Size episodes here and reach out to us on twitter or email us at samplesizeshow.gmail.com if you have any topics you want us to cover in the future!


    Please consider donating to organizations providing supplies and relief to India to help with the COVID-19 pandemic. Visit UNICEF or Mutual Aid India.  


    Sources: 

    https://www.npr.org/2021/06/07/1003964235/fda-approves-controversial-alzheimers-drug-aducanumab 

    https://www.npr.org/2021/06/11/1005567149/3-experts-have-resigned-from-an-fda-committee-over-alzheimers-drug-approval 

    https://www.nia.nih.gov/health/what-alzheimers-disease 

    https://www.forbes.com/sites/joewalsh/2021/06/17/manchin-wants-biden-to-oust-fda-chief-over-controversial-alzheimers-drug-approval/?sh=43bb08626c80 

    https://www.washingtonpost.com/health/2021/06/17/alzheimers-drug-controversy/ 

    https://pubmed.ncbi.nlm.nih.gov/33656288/ 

    https://www.fda.gov/advisory-committees 


    Support this show http://supporter.acast.com/sample-size.


    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Listen to hosts Samantha Spiers and Wildcard Cameron discuss the FDA's approval of Aduhelm, a new drug developed to treat those with Alzheimer's disease. Discussion includes what is this drug, why is its approval controversial, and why did the FDA go ahead and approve it.

    

Post production by Scott Stronach.   


Check out other Sample Size episodes here and reach out to us on twitter or email us at samplesizeshow.gmail.com if you have any topics you want us to cover in the future!


Please consider donating to organizations providing supplies and relief to India to help with the COVID-19 pandemic. Visit UNICEF or Mutual Aid India.  


Sources: 

https://www.npr.org/2021/06/07/1003964235/fda-approves-controversial-alzheimers-drug-aducanumab 

https://www.npr.org/2021/06/11/1005567149/3-experts-have-resigned-from-an-fda-committee-over-alzheimers-drug-approval 

https://www.nia.nih.gov/health/what-alzheimers-disease 

https://www.forbes.com/sites/joewalsh/2021/06/17/manchin-wants-biden-to-oust-fda-chief-over-controversial-alzheimers-drug-approval/?sh=43bb08626c80 

https://www.washingtonpost.com/health/2021/06/17/alzheimers-drug-controversy/ 

https://pubmed.ncbi.nlm.nih.gov/33656288/ 

https://www.fda.gov/advisory-committees 


Support this show http://supporter.acast.com/sample-size.


Hosted on Acast. See acast.com/privacy for more information.

A Drug to Rememberに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。